First external quality assurance of antibody diagnostic for SARS-new coronavirus
Identifieur interne : 004E25 ( Main/Exploration ); précédent : 004E24; suivant : 004E26First external quality assurance of antibody diagnostic for SARS-new coronavirus
Auteurs : Matthias Niedrig [Allemagne] ; Katrin Leitmeyer [Allemagne, Suisse] ; Wilina Lim [Hong Kong] ; Malik Peiris [Hong Kong] ; John S. Mackenzie [Suisse, Australie] ; Maria Zambon [Royaume-Uni]Source :
- Journal of clinical virology [ 1386-6532 ] ; 2005.
Descripteurs français
- KwdFr :
- Anticorps antiviraux (sang), Assurance de la qualité des soins de santé, Humains, Reproductibilité des résultats, Sensibilité et spécificité, Syndrome respiratoire aigu sévère (diagnostic), Syndrome respiratoire aigu sévère (immunologie), Syndrome respiratoire aigu sévère (sang), Tests immunologiques (normes), Virus du SRAS (immunologie).
- MESH :
- diagnostic : Syndrome respiratoire aigu sévère.
- immunologie : Syndrome respiratoire aigu sévère, Virus du SRAS.
- normes : Tests immunologiques.
- sang : Anticorps antiviraux, Syndrome respiratoire aigu sévère.
- Pascal (Inist)
English descriptors
- KwdEn :
- Antibodies, Viral (blood), Antibody, Humans, Immunologic Tests (standards), Microbiology, Quality Assurance, Health Care, Reproducibility of Results, SARS Virus (immunology), Sensitivity and Specificity, Severe Acute Respiratory Syndrome (blood), Severe Acute Respiratory Syndrome (diagnosis), Severe Acute Respiratory Syndrome (immunology), Severe acute respiratory syndrome, Severe acute respiratory syndrome virus, Virology.
- MESH :
- chemical , blood : Antibodies, Viral.
- blood : Severe Acute Respiratory Syndrome.
- diagnosis : Severe Acute Respiratory Syndrome.
- immunology : SARS Virus, Severe Acute Respiratory Syndrome.
- standards : Immunologic Tests.
- Humans, Quality Assurance, Health Care, Reproducibility of Results, Sensitivity and Specificity.
Abstract
To confirm an infection with the new coronavirus (SARS-CoV) causing the severe acute respiratory syndrome (SARS) diagnostic assays for detection of SARS-CoV specific antibody are necessary. To evaluate the diagnostic performance of laboratories an external quality assurance (EQA) study was performed in 2004. Participating laboratories (9/20) correctly detected anti-SARS antibodies in serum samples without false positive results in an immunofluorescence assay. In contrast, only 4/13 laboratories detected most of the anti-SARS antibody positive samples without false positive results using enzyme immunoassays (EIA) and/or immunoblot. The overall results clearly demonstrate that serological diagnosis of SARS-CoV remains at an early stage of development, with further technical improvements required, particularly with respect to the use of SARS specific ElAs.
Url:
Affiliations:
- Allemagne, Australie, Hong Kong, Royaume-Uni, Suisse
- Angleterre, Berlin, Grand Londres
- Berlin, Londres
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000621
- to stream PascalFrancis, to step Curation: 000369
- to stream PascalFrancis, to step Checkpoint: 000646
- to stream Main, to step Merge: 005166
- to stream Pmc, to step Corpus: 001119
- to stream Pmc, to step Curation: 001119
- to stream Pmc, to step Checkpoint: 001336
- to stream PubMed, to step Corpus: 002602
- to stream PubMed, to step Curation: 002602
- to stream PubMed, to step Checkpoint: 002706
- to stream Ncbi, to step Merge: 001098
- to stream Ncbi, to step Curation: 001098
- to stream Ncbi, to step Checkpoint: 001098
- to stream Main, to step Merge: 004B25
- to stream Main, to step Curation: 004E25
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">First external quality assurance of antibody diagnostic for SARS-new coronavirus</title><author><name sortKey="Niedrig, Matthias" sort="Niedrig, Matthias" uniqKey="Niedrig M" first="Matthias" last="Niedrig">Matthias Niedrig</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Robert Koch-Institute, Nordufer 20</s1><s2>13353 Berlin</s2><s3>DEU</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author><author><name sortKey="Leitmeyer, Katrin" sort="Leitmeyer, Katrin" uniqKey="Leitmeyer K" first="Katrin" last="Leitmeyer">Katrin Leitmeyer</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Robert Koch-Institute, Nordufer 20</s1><s2>13353 Berlin</s2><s3>DEU</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>World Health Organization</s1><s2>Geneva</s2><s3>CHE</s3><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Suisse</country><wicri:noRegion>World Health Organization</wicri:noRegion></affiliation></author><author><name sortKey="Lim, Wilina" sort="Lim, Wilina" uniqKey="Lim W" first="Wilina" last="Lim">Wilina Lim</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Government Virus Unit Hong Kong</s1><s3>HKG</s3><sZ>3 aut.</sZ></inist:fA14><country>Hong Kong</country><wicri:noRegion>Government Virus Unit Hong Kong</wicri:noRegion></affiliation></author><author><name sortKey="Peiris, Malik" sort="Peiris, Malik" uniqKey="Peiris M" first="Malik" last="Peiris">Malik Peiris</name><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Microbiology, The University of Hong Kong</s1><s3>HKG</s3><sZ>4 aut.</sZ></inist:fA14><country>Hong Kong</country><wicri:noRegion>Department of Microbiology, The University of Hong Kong</wicri:noRegion></affiliation></author><author><name sortKey="Mackenzie, John S" sort="Mackenzie, John S" uniqKey="Mackenzie J" first="John S." last="Mackenzie">John S. Mackenzie</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>World Health Organization</s1><s2>Geneva</s2><s3>CHE</s3><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Suisse</country><wicri:noRegion>World Health Organization</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Australian Biosecurity Cooperative Research Centre, Curtin University of Technology</s1><s2>Perth</s2><s3>AUS</s3><sZ>5 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Perth</wicri:noRegion></affiliation></author><author><name sortKey="Zambon, Maria" sort="Zambon, Maria" uniqKey="Zambon M" first="Maria" last="Zambon">Maria Zambon</name><affiliation wicri:level="3"><inist:fA14 i1="06"><s1>Health Protection Agency</s1><s2>London</s2><s3>GBR</s3><sZ>6 aut.</sZ></inist:fA14><country>Royaume-Uni</country><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">05-0385590</idno><date when="2005">2005</date><idno type="stanalyst">PASCAL 05-0385590 INIST</idno><idno type="RBID">Pascal:05-0385590</idno><idno type="wicri:Area/PascalFrancis/Corpus">000621</idno><idno type="wicri:Area/PascalFrancis/Curation">000369</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000646</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000646</idno><idno type="wicri:doubleKey">1386-6532:2005:Niedrig M:first:external:quality</idno><idno type="wicri:Area/Main/Merge">005166</idno><idno type="wicri:source">PMC</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7108360</idno><idno type="RBID">PMC:7108360</idno><idno type="wicri:Area/Pmc/Corpus">001119</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001119</idno><idno type="wicri:Area/Pmc/Curation">001119</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001119</idno><idno type="wicri:Area/Pmc/Checkpoint">001336</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001336</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:16087120</idno><idno type="wicri:Area/PubMed/Corpus">002602</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002602</idno><idno type="wicri:Area/PubMed/Curation">002602</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002602</idno><idno type="wicri:Area/PubMed/Checkpoint">002706</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002706</idno><idno type="wicri:Area/Ncbi/Merge">001098</idno><idno type="wicri:Area/Ncbi/Curation">001098</idno><idno type="wicri:Area/Ncbi/Checkpoint">001098</idno><idno type="wicri:doubleKey">1386-6532:2005:Niedrig M:first:external:quality</idno><idno type="wicri:Area/Main/Merge">004B25</idno><idno type="wicri:Area/Main/Curation">004E25</idno><idno type="wicri:Area/Main/Exploration">004E25</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">First external quality assurance of antibody diagnostic for SARS-new coronavirus</title><author><name sortKey="Niedrig, Matthias" sort="Niedrig, Matthias" uniqKey="Niedrig M" first="Matthias" last="Niedrig">Matthias Niedrig</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Robert Koch-Institute, Nordufer 20</s1><s2>13353 Berlin</s2><s3>DEU</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation></author><author><name sortKey="Leitmeyer, Katrin" sort="Leitmeyer, Katrin" uniqKey="Leitmeyer K" first="Katrin" last="Leitmeyer">Katrin Leitmeyer</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Robert Koch-Institute, Nordufer 20</s1><s2>13353 Berlin</s2><s3>DEU</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ></inist:fA14><country>Allemagne</country><placeName><region type="land" nuts="3">Berlin</region><settlement type="city">Berlin</settlement></placeName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>World Health Organization</s1><s2>Geneva</s2><s3>CHE</s3><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Suisse</country><wicri:noRegion>World Health Organization</wicri:noRegion></affiliation></author><author><name sortKey="Lim, Wilina" sort="Lim, Wilina" uniqKey="Lim W" first="Wilina" last="Lim">Wilina Lim</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Government Virus Unit Hong Kong</s1><s3>HKG</s3><sZ>3 aut.</sZ></inist:fA14><country>Hong Kong</country><wicri:noRegion>Government Virus Unit Hong Kong</wicri:noRegion></affiliation></author><author><name sortKey="Peiris, Malik" sort="Peiris, Malik" uniqKey="Peiris M" first="Malik" last="Peiris">Malik Peiris</name><affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Microbiology, The University of Hong Kong</s1><s3>HKG</s3><sZ>4 aut.</sZ></inist:fA14><country>Hong Kong</country><wicri:noRegion>Department of Microbiology, The University of Hong Kong</wicri:noRegion></affiliation></author><author><name sortKey="Mackenzie, John S" sort="Mackenzie, John S" uniqKey="Mackenzie J" first="John S." last="Mackenzie">John S. Mackenzie</name><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>World Health Organization</s1><s2>Geneva</s2><s3>CHE</s3><sZ>2 aut.</sZ><sZ>5 aut.</sZ></inist:fA14><country>Suisse</country><wicri:noRegion>World Health Organization</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Australian Biosecurity Cooperative Research Centre, Curtin University of Technology</s1><s2>Perth</s2><s3>AUS</s3><sZ>5 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Perth</wicri:noRegion></affiliation></author><author><name sortKey="Zambon, Maria" sort="Zambon, Maria" uniqKey="Zambon M" first="Maria" last="Zambon">Maria Zambon</name><affiliation wicri:level="3"><inist:fA14 i1="06"><s1>Health Protection Agency</s1><s2>London</s2><s3>GBR</s3><sZ>6 aut.</sZ></inist:fA14><country>Royaume-Uni</country><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></analytic><series><title level="j" type="main">Journal of clinical virology</title><title level="j" type="abbreviated">J. clin. virol.</title><idno type="ISSN">1386-6532</idno><imprint><date when="2005">2005</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Journal of clinical virology</title><title level="j" type="abbreviated">J. clin. virol.</title><idno type="ISSN">1386-6532</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Viral (blood)</term><term>Antibody</term><term>Humans</term><term>Immunologic Tests (standards)</term><term>Microbiology</term><term>Quality Assurance, Health Care</term><term>Reproducibility of Results</term><term>SARS Virus (immunology)</term><term>Sensitivity and Specificity</term><term>Severe Acute Respiratory Syndrome (blood)</term><term>Severe Acute Respiratory Syndrome (diagnosis)</term><term>Severe Acute Respiratory Syndrome (immunology)</term><term>Severe acute respiratory syndrome</term><term>Severe acute respiratory syndrome virus</term><term>Virology</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Anticorps antiviraux (sang)</term><term>Assurance de la qualité des soins de santé</term><term>Humains</term><term>Reproductibilité des résultats</term><term>Sensibilité et spécificité</term><term>Syndrome respiratoire aigu sévère (diagnostic)</term><term>Syndrome respiratoire aigu sévère (immunologie)</term><term>Syndrome respiratoire aigu sévère (sang)</term><term>Tests immunologiques (normes)</term><term>Virus du SRAS (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>SARS Virus</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Tests immunologiques</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Immunologic Tests</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Quality Assurance, Health Care</term><term>Reproducibility of Results</term><term>Sensitivity and Specificity</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Assurance de la qualité des soins de santé</term><term>Humains</term><term>Reproductibilité des résultats</term><term>Sensibilité et spécificité</term><term>Virus syndrome respiratoire aigu sévère</term><term>Anticorps</term><term>Microbiologie</term><term>Virologie</term><term>Syndrome respiratoire aigu sévère</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To confirm an infection with the new coronavirus (SARS-CoV) causing the severe acute respiratory syndrome (SARS) diagnostic assays for detection of SARS-CoV specific antibody are necessary. To evaluate the diagnostic performance of laboratories an external quality assurance (EQA) study was performed in 2004. Participating laboratories (9/20) correctly detected anti-SARS antibodies in serum samples without false positive results in an immunofluorescence assay. In contrast, only 4/13 laboratories detected most of the anti-SARS antibody positive samples without false positive results using enzyme immunoassays (EIA) and/or immunoblot. The overall results clearly demonstrate that serological diagnosis of SARS-CoV remains at an early stage of development, with further technical improvements required, particularly with respect to the use of SARS specific ElAs.</div></front></TEI><affiliations><list><country><li>Allemagne</li><li>Australie</li><li>Hong Kong</li><li>Royaume-Uni</li><li>Suisse</li></country><region><li>Angleterre</li><li>Berlin</li><li>Grand Londres</li></region><settlement><li>Berlin</li><li>Londres</li></settlement></list><tree><country name="Allemagne"><region name="Berlin"><name sortKey="Niedrig, Matthias" sort="Niedrig, Matthias" uniqKey="Niedrig M" first="Matthias" last="Niedrig">Matthias Niedrig</name></region><name sortKey="Leitmeyer, Katrin" sort="Leitmeyer, Katrin" uniqKey="Leitmeyer K" first="Katrin" last="Leitmeyer">Katrin Leitmeyer</name></country><country name="Suisse"><noRegion><name sortKey="Leitmeyer, Katrin" sort="Leitmeyer, Katrin" uniqKey="Leitmeyer K" first="Katrin" last="Leitmeyer">Katrin Leitmeyer</name></noRegion><name sortKey="Mackenzie, John S" sort="Mackenzie, John S" uniqKey="Mackenzie J" first="John S." last="Mackenzie">John S. Mackenzie</name></country><country name="Hong Kong"><noRegion><name sortKey="Lim, Wilina" sort="Lim, Wilina" uniqKey="Lim W" first="Wilina" last="Lim">Wilina Lim</name></noRegion><name sortKey="Peiris, Malik" sort="Peiris, Malik" uniqKey="Peiris M" first="Malik" last="Peiris">Malik Peiris</name></country><country name="Australie"><noRegion><name sortKey="Mackenzie, John S" sort="Mackenzie, John S" uniqKey="Mackenzie J" first="John S." last="Mackenzie">John S. Mackenzie</name></noRegion></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Zambon, Maria" sort="Zambon, Maria" uniqKey="Zambon M" first="Maria" last="Zambon">Maria Zambon</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004E25 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004E25 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:05-0385590
|texte= First external quality assurance of antibody diagnostic for SARS-new coronavirus
}}
| This area was generated with Dilib version V0.6.33. |  |